ARMLOGI HOLDING CORP. TO ANNOUNCE FISCAL 2025 SECOND QUARTER AND SIX-MONTH RESULTS ON THURSDAY, FEBRUARY 13
WALNUT, CA, Feb. 07, 2025 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing […]
Fitell Corporation Announces $10.0 Million Registered Direct Offering
TAREN POINT, Australia, Feb. 07, 2025 (GLOBE NEWSWIRE) — Fitell Corporation (Nasdaq: FTEL) (“Fitell” or the “Company”), an online retailer […]
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase […]
LiveOne (NASDAQ: LVO) to Announce Third Quarter Fiscal Year 2025 Financial Results and Host Investor Webcast on Friday, February 14, 2025
LOS ANGELES, Feb. 07, 2025 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, plans […]
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing […]
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
HANOVER, Md., Feb. 07, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical […]
Arq Provides Update on Transformational GAC Project
Construction of Arq’s GAC production facility remains on schedule, with initial production expected in Q1 2025 Customer negotiations for GAC […]
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) — PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused […]
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock
MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced that it has priced […]
Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics
– University of Waterloo’s Faculty of Engineering Recognizes Dr. Wilson with Faculty Research Excellence Award – – Esteemed researchers and […]
